Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.
A patient with acute erythroleukemia secondary to polycythemia vera was treated iv with high-dose cytarabine at a dose of 3 g/m2 every 12 hours. After the fourth dose, he developed an expressive (Broca's type) aphasia and somnolence, which progressed until after the treatment was stopped at the seventh dose. The somnolence cleared partially during the next 2 weeks but recurred after cytarabine was restarted at a dose of 100 mg/m2 daily for 7 days. The patient died 5 days later of refractory extreme thrombocytopenia and bleeding. The normal spinal fluid obtained during life and the postmortem findings were consistent with previously reported findings with central nervous system toxicity from high-dose cytarabine. Three unusual aspects of this case are early onset of symptoms, expressive aphasia as the dominant manifestation, and exacerbation of symptoms with standard doses (100 mg/m2/day).
D001037:Aphasia / Q000139:chemically induced*; D001039:Aphasia, Broca / Q000139:chemically induced* / Q000473:pathology; D002452:Cell Count; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000188:drug therapy; D011689:Purkinje Cells / Q000473:pathology; D013997:Time Factors
D003561:Cytarabine